Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.


Summaries of Product Characteristics 181 - 210 of 324
Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti

Minims Atropine Sulphate 10 mg-ml silmätipat, liuos, kerta-annospakkaus SPC 2022-02-18

PL

Resepti

Minims Oxybuprocaine Hydrochloride 4 mg-ml silmätipat, liuos, kerta-annospakkaus SPC 2022-02-18

PL

Resepti

Minirin 2.5 mikrog-annos nenäsumute, liuos SPC 2022-11-28

PL

Resepti

Minirin 60 mikrog, 120 mikrog ja 240 mikrog tabletti, kylmäkuivattu SPC 2020-09-29

European Medicines Agency's website:
MINJUVI - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Minulet tabletti, päällystetty SPC 2022-10-12

PL

Resepti

Miochol-E 10 mg-ml jauhe ja liuotin instillaatioliuosta varten, silmän sisään SPC 2022-02-07

PL

Resepti

Mirabegron ratiopharm 50 mg depottabletit SPC 2024-08-22

PL

Resepti

Mirabegron Stada 50 mg depottabletti SPC 2024-09-02

PL

Resepti

Miranax 550 mg tabletti, kalvopäällysteinen SPC 2024-09-18

European Medicines Agency's website:
Mirapexin - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Mircera - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Mirena 20 mikrog-24 tuntia depotlääkevalmiste, kohtuun SPC 2024-04-24

PL

Resepti

Mirtagav 15 mg, 30 mg 45 mg tabletti SPC 2010-05-05

PL

Resepti

Mirtamerck 15 mg tabletti SPC 2005-05-11

PL

Resepti

Mirtamerck 30 mg tabletti SPC 2005-05-11

PL

Resepti

Mirtamerck 45 mg tabletti SPC 2005-05-11

PL

Resepti

Mirtazapin Actavis 15 mg, 30 mg tabletti, kalvopäällysteinen SPC 2023-05-30

PL

Resepti

Mirtazapin Hexal 15 mg, 30 mg ,45 mg tabletti, kalvopäällysteinen SPC 2021-04-16

PL

Resepti

Mirtazapin Krka 15 mg, 30 mg, 45 mg tabletti, kalvopäällysteinen SPC 2021-11-22

PL

Resepti

Mirtazapin Orion 15 mg, 30 mg, 45 mg tabletti, kalvopäällysteinen SPC 2021-12-23

PL

Resepti

Mirtazapin Orion 15 mg, 30 mg, 45 mg tabletti, suussa hajoava SPC 2021-06-28

PL

Resepti

Mirtazapin ratiopharm 15 mg, 30 mg tabletti, kalvopäällysteinen SPC 2021-09-16

PL

Resepti

Mirtazapin ratiopharm 45 mg tabletti, kalvopäällysteinen SPC 2023-05-30

PL

Resepti

Mirtazapin Sandoz 15 mg, 30 mg, 45 mg tabletti SPC 2024-02-22

PL

Resepti

Mirtazapin Teva 15 mg, 30 mg, 45 mg tabletti, kalvopäällysteinen SPC 2023-03-24

PL

Resepti

Mirtazapine Actavis 15, 30, 45 mg tabletti SPC 2006-01-24

PL

Resepti

Mirtazapine STADA 15 mg, 30 mg, 45 mg tabletti SPC 2010-05-28.doc

European Medicines Agency's website:
Mirvaso - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Misbadi 110 mg kapseli, kova SPC 2022-06-01.docx

Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >